secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2026-10-01T10:52:00+00:00
Accession:  0000721371-26-000041
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Cardinal Health extends CVS distribution pact to June 2032; reaffirms FY2027 EPS guidance of $12.40-$12.60
--------------------------------------------------------------------------------

- Binding letter of intent extends Cardinal Health's existing pharmaceutical distribution agreement with CVS Health through June 30, 2032, continuing the current scope of distribution services.
- FY2027 non-GAAP EPS guidance reaffirmed at $12.40 to $12.60, which the company said equals 13% to 15% growth.
- Long-term non-GAAP EPS growth guidance of 12% to 14% reiterated alongside the renewal.
- CEO Jason Hollar cited the 'long-standing partnership with CVS Health'; further updates may come on the Q1 earnings call scheduled for November 5, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000041/0000721371-26-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000041/cah-20261001.htm
  HTML page:      https://secwatch.observer/filing/0000721371-26-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer